Skip to main content
. 2020 Jun 8;117(25):14331–14341. doi: 10.1073/pnas.1916206117

Fig. 3.

Fig. 3.

Comparison of clinical characteristics of proliferator and nonproliferator samples. (A) Mutations from whole exome sequencing, ranked in order of prevalence. (BD) Box-and-whisker plots denoting medians and interquartile ranges of (B) age of patient at time of sample collection, (C) WBC count in peripheral blood and (D) blast percentage in the bone marrow. P values are from the Kruskal–Wallis test. (E) ELN risk group distribution.